MPC Therapeutics AG
PrivateLast Round
Seed
Nov 16, 2023
Total Funding Raised
$1.74M
Company Overview
MPC Therapeutics AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Seed round in November 2023.
MPC Therapeutics AG is a biotechnology research company that develops a new generation of cancer therapies that modulate transcription.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MPC Therapeutics AG Comparables
Compare MPC Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RORA Biologics | 74% | |
| Miltenyi Biotec | 63% | |
| Lmito Therapeutics | 63% |
For institutional investors. Book with your work email.
MPC Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 16, 2023 | ||||
| Seed | Jan 10, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MPC Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plutus Investment Group | Seed |
| Fongit | Seed |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors grew 146% MoM, reaching 5.9K.
- Dec 16, 2024
Monthly visitors grew 213% MoM, reaching 4.7K.
For institutional investors. Book with your work email.
MPC Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MPC Therapeutics AG's valuation, stock price, and market status.
Is MPC Therapeutics AG a public or private company?
MPC Therapeutics AG is a private company.
What is the current stock price of MPC Therapeutics AG?
MPC Therapeutics AG is a private company, so its shares have no public market price. Caplight tracks MPC Therapeutics AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MPC Therapeutics AG worth (valuation)?
Valuation information for MPC Therapeutics AG is not publicly available.
Can I buy MPC Therapeutics AG stock?
MPC Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MPC Therapeutics AG's last funding round?
MPC Therapeutics AG's most recent funding round was Seed on November 16, 2023.
Who are the main investors in MPC Therapeutics AG?
Key investors in MPC Therapeutics AG include Plutus Investment Group.
Will MPC Therapeutics AG IPO soon?
No public IPO plans have been announced for MPC Therapeutics AG.
How can I track MPC Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades in MPC Therapeutics AG's shares on secondary markets.